{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:45:56Z","timestamp":1776746756525,"version":"3.51.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to develop and validate a CT-based radiomics model for predicting pain relief after palliative radiotherapy in patients with bone metastases, and to compare the performance of 11 machine learning algorithms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively enrolled patients with bone metastases who received palliative radiotherapy at Xuzhou Central Hospital (Center 1) and Xuzhou First People\u2019s Hospital (Center 2) between January 2022 and December 2024. All patients completed a prescribed dose of 40 Gy in 20 fractions or 30 Gy in 10 fractions. Clinical variables\u2014including age, sex, primary tumor type, pattern of bone destruction, and metastatic site\u2014were collected alongside CT images. Pain response was assessed per the International Consensus on Endpoints for Palliative Radiotherapy in Bone Metastases: complete response (CR) and partial response (PR) were grouped as the relief group, while progressive disease (PD) and stable disease (SD) constituted the non-relief group. ROIs were delineated over the tumor areas on bone-window CT images, and radiomic features were extracted, normalized, and screened to construct a radiomics signature. Eleven machine learning classifiers were trained and compared; the optimal model was selected for predictive performance evaluation and clinical applicability analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 134 eligible patients were included (pain relief group: n = 53; non-relief group: n = 81). Center 1 patients were randomly split approximately 8:2 into training (n = 91) and internal validation (n = 26) sets; Center 2 served as the external test set (n = 17). No significant differences existed between the two centers in baseline demographics, tumor-related variables, or treatment parameters, except for bone-protective drug use and bone metastasis site. After feature selection, 7 radiomic features remained for modeling. Among 11 tested machine learning models, the k-nearest neighbors (KNN) model demonstrated the best performance: area under the receiver operating characteristic curve (AUC) was 0.823 (95% confidence interval (CI): 0.743\u20130.903) in the training set, 0.812 (95% CI: 0.661\u20130.964) in the internal validation set, and 0.818 (95% CI: 0.556\u20131.000) in the external test set. Decision curve analysis (DCA) indicated favorable net clinical benefit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The KNN model based on CT radiomics can effectively predict pain relief outcomes after palliative radiotherapy in patients with bone metastases, showing potential clinical utility, and may help identify patients likely to achieve pain relief from radiotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1813913","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:22:15Z","timestamp":1776745335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A CT-based radiomics model for predicting pain relief after radiotherapy in patients with bone metastases: a dual-center study"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhiling","family":"Wan","sequence":"first","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangning","family":"Liu","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heyao","family":"Xu","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Department of Radiation Oncology, XuZhou Clinical School of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohan","family":"Qin","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zexian","family":"Wang","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijia","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Wu","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Hu","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Department of Radiation Oncology, Xuzhou Central Hospital","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Department of Radiation Oncology, Xuzhou Central Hospital","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[{"name":"The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Department of Radiation Oncology, Xuzhou Central Hospital","place":["Xuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO clinical practice guidelines","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.55409","article-title":"Stereotactic body and conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis","volume":"7","author":"Bindels","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases","volume":"24","author":"Chow","year":"2012","journal-title":"Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.01.050","article-title":"Pain response rates after conventional radiation therapy for bone metastases assessed using international consensus pain response endpoints: a systematic review and meta-analysis of initial radiation therapy and reirradiation","volume":"116","author":"Imano","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111263","article-title":"Pain response of patients treated with radiotherapy for painful bone metastases between 2013 and 2024-an analysis of the prospective real-world PRESENT cohort","volume":"214","author":"Hovenier","year":"2026","journal-title":"Radiother Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicenter, randomized, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2024.04.018","article-title":"External beam radiation therapy for palliation of symptomatic bone metastases: an ASTRO clinical practice guideline","volume":"14","author":"Alcorn","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.07.029","article-title":"Development and internal validation of a clinical risk score to predict pain response after palliative radiation therapy in patients with bone metastases","volume":"99","author":"van der Velden","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(19)30058-5","article-title":"An image-based deep learning framework for individualizing radiotherapy dose: a retrospective analysis of outcome prediction","volume":"1","author":"Lou","year":"2019","journal-title":"Lancet Dig Health"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-022-2535-2","article-title":"Application of unenhanced computed tomography texture analysis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma","volume":"42","author":"Ren","year":"2022","journal-title":"Curr Med Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v17.i8.109373","article-title":"Developing and validating a computed tomography radiomics strategy to predict lymph node metastasis in pancreatic cancer","volume":"17","author":"Ren","year":"2025","journal-title":"World J Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2023.03.003","article-title":"The promise and future of radiomics for personalized radiotherapy dosing and adaptation","volume":"33","author":"Ger","year":"2023","journal-title":"Semin Radiat Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2021.00311","article-title":"Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases","volume":"39","author":"Cheung","year":"2021","journal-title":"Radiat Oncol J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1038","article-title":"Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"23","author":"Liu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol33010065","article-title":"Artificial intelligence and machine learning in bone metastasis management: a narrative review","volume":"33","author":"Bulut","year":"2026","journal-title":"Curr Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.70189","article-title":"CT imaging-based radiomics predicts the pain relief of Strontium-89 in treating tumor-induced bone metastases","volume":"26","author":"Fang","year":"2025","journal-title":"J Appl Clin Med Phys"},{"key":"B20","doi-asserted-by":"publisher","first-page":"17427","DOI":"10.1038\/s41598-023-43768-6","article-title":"The importance of planning CT-based imaging features for machine learning-based prediction of pain response","volume":"13","author":"Llori\u00e1n-Salvador","year":"2023","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"12908","DOI":"10.1038\/s41598-021-92363-0","article-title":"A predictive model for pain response following radiotherapy for treatment of spinal metastases","volume":"11","author":"Wakabayashi","year":"2021","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.190736","article-title":"Test\u2013retest variability in lesion SUV and lesion SUR in 18F-FDG PET: an analysis of data from two prospective multicenter trials","volume":"58","author":"Hofheinz","year":"2017","journal-title":"J Nucl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.02.008","article-title":"Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases","volume":"82","author":"Chow","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"Morbid Mortal Wkly Rep: Recommend Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1200\/JCO.22.01357","article-title":"Integrative medicine for pain management in oncology: society for integrative oncology\u2013ASCO guideline","volume":"40","author":"Mao","year":"2022","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab262","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"24","author":"Vogelbaum","year":"2022","journal-title":"Neuro-Oncology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ijrobp.2015.06.024","article-title":"Quality of life in relation to pain response to radiation therapy for painful bone metastases","volume":"93","author":"Westhoff","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018172300","article-title":"MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy","volume":"287","author":"Horvat","year":"2018","journal-title":"Radiology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.211986","article-title":"MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy","volume":"303","author":"Shin","year":"2022","journal-title":"Radiology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41571-022-00707-0","article-title":"Criteria for the translation of radiomics into clinically useful tests","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256152","article-title":"Radiomics machine learning study with a small sample size: single random training-test set split may lead to unreliable results","volume":"16","author":"An","year":"2021","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2018.0070","article-title":"Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives","volume":"20","author":"Park","year":"2019","journal-title":"Korean J Radiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109969","article-title":"Efficacy and safety of SBRT for spine metastases: a systematic review and meta-analysis for preparation of an ESTRO practice guideline","volume":"190","author":"Guninski","year":"2024","journal-title":"Radiother Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.6770","article-title":"Effect of radiotherapy on painful bone metastases: a secondary analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23","volume":"3","author":"McDonald","year":"2017","journal-title":"JAMA Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10555-025-10262-6","article-title":"State-of-the-art of multidisciplinary approach of bone metastasis-directed therapy: review and challenging questions for preparation of a GEMO practice guidelines","volume":"44","author":"Mesny","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.02198","article-title":"Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline","volume":"41","author":"Paice","year":"2023","journal-title":"J Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/ijms17091391","article-title":"Bone density as a marker of response to radiotherapy in bone metastatic lesions: a review of the published data","volume":"17","author":"Kouloulias","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.04.004","article-title":"Radiomic phenotype features predict pathological response in non-small cell lung cancer","volume":"119","author":"Coroller","year":"2016","journal-title":"Radiother Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140369","article-title":"The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning","volume":"87","author":"Alobaidli","year":"2014","journal-title":"Br J Radiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1038\/s41598-018-22357-y","article-title":"Radiomics analysis at PET\/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy","volume":"8","author":"Oikonomou","year":"2018","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122869","article-title":"Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy","volume":"270","author":"Yip","year":"2014","journal-title":"Radiology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aa6ae5","article-title":"Multi-objective radiomics model for predicting distant failure in lung SBRT","volume":"62","author":"Zhou","year":"2017","journal-title":"Phys Med Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in medical imaging\u2014\u201chow-to\u201d guide and critical reflection","volume":"11","author":"Van Timmeren","year":"2020","journal-title":"Insights into Imaging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017170056","article-title":"CT texture analysis: definitions, applications, biologic correlates, and challenges","volume":"37","author":"Lubner","year":"2017","journal-title":"Rad Graphics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40644-020-00341-y","article-title":"The application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges","volume":"20","author":"Masokano","year":"2020","journal-title":"Cancer Imaging"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6120703","article-title":"A new challenge for radiologists: radiomics in breast cancer","volume":"2018","author":"Crivelli","year":"2018","journal-title":"BioMed Res Int"},{"key":"B48","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.3390\/ijms26146679","article-title":"Use of radiomics in characterizing tumor hypoxia","volume":"26","author":"Huang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.radonc.2020.10.016","article-title":"Non-invasive imaging prediction of tumor hypoxia: a novel developed and externally validated CT and FDG-PET-based radiomic signatures","volume":"153","author":"Sanduleanu","year":"2020","journal-title":"Radiother Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.15199","article-title":"Value of CT-based radiomics in evaluating the response of bone metastases to systemic drug therapy in breast cancer patients","volume":"15","author":"He","year":"2024","journal-title":"Thorac Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"v662","DOI":"10.1093\/annonc\/mdz261.003","article-title":"1601P - Clinical predictors for analgesic response to radiotherapy in patients with painful bone metastases","volume":"30","author":"Habberstad","year":"2019","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:22:16Z","timestamp":1776745336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":51,"alternative-id":["10.3389\/fonc.2026.1813913"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1813913","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1813913"}}